Dogwood Therapeutics, Inc.
DWTX
$1.70
$0.010.59%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 75.99% | -313.53% | 65.15% | -41.37% | -238.84% |
| Total Depreciation and Amortization | -4.05% | 0.00% | 1.76% | 39.34% | -- |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | -10.27% | -- |
| Total Other Non-Cash Items | -99.32% | 20,054.67% | -99.06% | 74.00% | 3,810.29% |
| Change in Net Operating Assets | -87.75% | 222.20% | -21.81% | 88.76% | -269.38% |
| Cash from Operations | -11.13% | 18.71% | 14.02% | 23.63% | -573.72% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -100.00% | -80.42% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 99.43% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 100.00% | -101.63% | -51.88% | 21,926.64% |
| Foreign Exchange rate Adjustments | 181.82% | -132.67% | 741.67% | 100.83% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.95% | 20.79% | -253.70% | -78.99% | 1,406.42% |